Ferris Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,171
Closed -$315K 176
2019
Q3
$315K Sell
3,171
-4,883
-61% -$464K 0.11% 134
2019
Q2
$745K Hold
8,054
0.28% 86
2019
Q1
$760K Buy
8,054
+381
+5% +$33.3K 0.28% 82
2018
Q4
$492K Hold
7,673
0.22% 98
2018
Q3
$687K Sell
7,673
-94
-1% -$8.31K 0.27% 76
2018
Q2
$617K Sell
7,767
-1,200
-13% -$99.6K 0.26% 75
2018
Q1
$800K Buy
8,967
+51
+0.6% +$4.9K 0.32% 66
2017
Q4
$930K Sell
8,916
-34
-0.4% -$3.84K 0.33% 68
2017
Q3
$1.3M Buy
8,950
+214
+2% +$29.1K 0.64% 32
2017
Q2
$1.14M Buy
+8,736
New +$1.07M 0.53% 37

Other funds holding CELG

Ferris Capital's CELG Position: Q4 2019 in Review

Ferris Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,171 shares — an estimated $315K sold.

Ferris Capital first reported a position in CELG in Q2 2017 and held it in 10 quarters. The position peaked at $1.3M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Ferris Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Ferris Capital sold 3,171 Celgene Corp shares in Q4 2019, an estimated $315K.
  • Ferris Capital first reported a position in Celgene Corp in Q2 2017 and held it in 10 quarters.
  • Ferris Capital's Celgene Corp position peaked at $1.3M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Ferris Capital's 13F filing for Q4 2019, filed 24 Jan 2020.